And this is the last we will ever hear of it.
Baloney. Anyone with such a drug would become a billionaire.
There have been some great new treatments out for specific cancers and specific protien markers. Look at Rituxan for an example.
https://en.m.wikipedia.org/wiki/Rituximab
“And this is the last we will ever hear of it.”
I’d call you a doubting Thomas, but over the years I have seen similar medical reports, and each time nothing happens. Too much money in continuing disease.
Only 25% of original studies are replicated. $$$$